# Novo Nordisk (NVO) total assets: DKK 542.90B in 2025

URL: https://funkfolio.com/stock/NVO/total-assets

> Novo Nordisk (NVO) total assets were DKK 542.90B at the end of fiscal 2025, up 16.6% from fiscal 2024. Year-by-year chart and table.

---

## Novo Nordisk (NVO) total assets

**Total assets · fiscal 2025:** DKK 542.90B at Dec 31, 2025

Novo Nordisk (NVO) had total assets of DKK 542.90B at the end of fiscal 2025 (December 31, 2025). That is 16.6% higher than the DKK 465.63B of fiscal 2024. Figures as of 18 Nov 2026, 09:40 UTC, from Yahoo Finance.

### Key facts

- **Total assets, fiscal 2025:** DKK 542.90B
- **Change on fiscal 2024:** +16.6%
- **Highest on record:** DKK 542.90B fiscal 2025
- **Lowest on record:** DKK 241.26B fiscal 2022
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 09:40 UTC. Statements from Yahoo Finance. Amounts are in DKK. Figures, not advice.

### Novo Nordisk total assets, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was DKK 542.90B in fiscal 2025 and the lowest DKK 241.26B in fiscal 2022.

### Total assets by fiscal year

### Novo Nordisk total assets, year by year

Novo Nordisk (NVO) total assets by fiscal year

| Fiscal year | Total assets | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | DKK 542.90B | 16.6% up | Dec 31, 2025 |
| 2024 | DKK 465.63B | 48.1% up | Dec 31, 2024 |
| 2023 | DKK 314.49B | 30.4% up | Dec 31, 2023 |
| 2022 | DKK 241.26B | — | Dec 31, 2022 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

### How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

### Total assets at health care companies of similar size

Total assets of Novo Nordisk and comparable companies

| Company | Total assets | Fiscal year |
| --- | --- | --- |
| [Gilead Sciences GILD](https://funkfolio.com/stock/GILD/total-assets) | $59.02B | 2025 |
| [Abbott Laboratories ABT](https://funkfolio.com/stock/ABT/total-assets) | $86.71B | 2025 |
| Novo Nordisk NVO | DKK 542.90B | 2025 |
| [Pfizer PFE](https://funkfolio.com/stock/PFE/total-assets) | $208.16B | 2025 |
| [Danaher DHR](https://funkfolio.com/stock/DHR/total-assets) | $83.46B | 2025 |
| [Intuitive Surgical ISRG](https://funkfolio.com/stock/ISRG/total-assets) | $20.46B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### Novo Nordisk, figure by figure

- [Novo Nordisk market cap](https://funkfolio.com/stock/NVO/market-cap)
- [Novo Nordisk revenue](https://funkfolio.com/stock/NVO/revenue)
- [Novo Nordisk earnings](https://funkfolio.com/stock/NVO/earnings)
- [Novo Nordisk earnings per share (EPS)](https://funkfolio.com/stock/NVO/eps)
- [Novo Nordisk P/E ratio](https://funkfolio.com/stock/NVO/pe-ratio)
- [Novo Nordisk P/S ratio](https://funkfolio.com/stock/NVO/ps-ratio)
- [Novo Nordisk P/B ratio](https://funkfolio.com/stock/NVO/pb-ratio)
- [Novo Nordisk free cash flow](https://funkfolio.com/stock/NVO/free-cash-flow)
- [Novo Nordisk operating margin](https://funkfolio.com/stock/NVO/operating-margin)
- [Novo Nordisk dividend](https://funkfolio.com/stock/NVO/dividend)
- [Novo Nordisk shares outstanding](https://funkfolio.com/stock/NVO/shares-outstanding)
- [Novo Nordisk total debt](https://funkfolio.com/stock/NVO/total-debt)
- [Novo Nordisk cash on hand](https://funkfolio.com/stock/NVO/cash)
- [Novo Nordisk return on equity (ROE)](https://funkfolio.com/stock/NVO/roe)
- [Novo Nordisk return on invested capital (ROIC)](https://funkfolio.com/stock/NVO/roic)

[Novo Nordisk (NVO) overview: price, valuation and scorecard](https://funkfolio.com/stock/NVO) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Novo Nordisk total assets: questions and answers

**How large are Novo Nordisk's total assets?**

Novo Nordisk (NVO) had total assets of DKK 542.90B at the end of fiscal 2025 (December 31, 2025). That is 16.6% higher than the DKK 465.63B of fiscal 2024.

**What are the highest and lowest total assets figures on record for Novo Nordisk?**

Across the 4 fiscal years on record (2022–2025), the highest was DKK 542.90B in fiscal 2025 and the lowest DKK 241.26B in fiscal 2022.

**How is Novo Nordisk's total assets calculated?**

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Novo Nordisk it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: total assets

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Novo Nordisk (NVO) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/NVO/total-assets

Underlying data: Yahoo Finance.
